Yanke Liang

Person

Brookline, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of cyclin-dependent kinase 7 (CDK7)
- Patent number 12,168,663
- Issue date Dec 17, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of salt-inducible kinase (SIK) inhibitors for treating osteopo...
- Patent number 12,121,521
- Issue date Oct 22, 2024
- The General Hospital Corporation
- Marc Wein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 12,076,405
- Issue date Sep 3, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 12,048,748
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperidine Degronimers for Target Protein degradation
- Patent number 12,048,747
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 11,992,531
- Issue date May 28, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of pyrimidopyrimidinones as SIK inhibitors
- Patent number 11,878,019
- Issue date Jan 23, 2024
- The General Hospital Corporation
- David E. Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...
- Patent number 11,827,636
- Issue date Nov 28, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic urea kinase inhibitors and uses thereof
- Patent number 11,725,011
- Issue date Aug 15, 2023
- The General Hospital Corporation
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
- Patent number 11,708,354
- Issue date Jul 25, 2023
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone and indazole compounds for the degradation of EGFR
- Patent number 11,673,902
- Issue date Jun 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N/O-linked Degrons and Degronimers for protein degradation
- Patent number 11,459,335
- Issue date Oct 4, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of pyrimidopyrimidinones as SIK inhibitors
- Patent number 11,285,158
- Issue date Mar 29, 2022
- The General Hospital Corporation
- David E. Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...
- Patent number 11,247,991
- Issue date Feb 15, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of salt-inducible kinase (SIK) inhibitors for treating osteopo...
- Patent number 11,241,435
- Issue date Feb 8, 2022
- The General Hospital Corporation
- Marc Wein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 11,185,592
- Issue date Nov 30, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl kinase inhibitors and uses thereof
- Patent number 10,975,058
- Issue date Apr 13, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic urea kinase inhibitors and uses thereof
- Patent number 10,954,242
- Issue date Mar 23, 2021
- The Broad Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,905,768
- Issue date Feb 2, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
- Patent number 10,882,848
- Issue date Jan 5, 2021
- Hoffmann-La Roche, Inc.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of cyclin-dependent kinase 7 (CDK7)
- Patent number 10,870,651
- Issue date Dec 22, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...
- Patent number 10,865,205
- Issue date Dec 15, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation...
- Patent number 10,865,204
- Issue date Dec 15, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 10,849,982
- Issue date Dec 1, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 10,660,968
- Issue date May 26, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,646,575
- Issue date May 12, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of C...
- Patent number 10,532,103
- Issue date Jan 14, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic kinase inhibitors and uses thereof
- Patent number 10,457,691
- Issue date Oct 29, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl kinase inhibitors and uses thereof
- Patent number 10,287,268
- Issue date May 14, 2019
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Uses of salt-inducible kinase (SIK) inhibitors
- Patent number 10,265,321
- Issue date Apr 23, 2019
- Dana-Farber Cancer Institute, Inc.
- Alykhan Shamji
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...
- Publication number 20240398959
- Publication date Dec 5, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
- Publication number 20240245695
- Publication date Jul 25, 2024
- The General Hospital Corporation
- David E. Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF
- Publication number 20240199581
- Publication date Jun 20, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveshuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
- Publication number 20240158418
- Publication date May 16, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20240076300
- Publication date Mar 7, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...
- Publication number 20230372496
- Publication date Nov 23, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N/O-Linked Degrons and Degronimers for Protein Degradation
- Publication number 20230279023
- Publication date Sep 7, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Application
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF
- Publication number 20230242534
- Publication date Aug 3, 2023
- Dana-Farber Cancer Institute, Inc.
- Tinghu Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF
- Publication number 20230234959
- Publication date Jul 27, 2023
- THE BROAD INSTITUTE, INC.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF RET
- Publication number 20230233692
- Publication date Jul 27, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRAF DEGRADERS
- Publication number 20230145336
- Publication date May 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20230110648
- Publication date Apr 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230095223
- Publication date Mar 30, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20230024096
- Publication date Jan 26, 2023
- HOFFMANN-LA ROCHE INC.
- Martin DUPLESSIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230014124
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS
- Publication number 20230002367
- Publication date Jan 5, 2023
- HOFFMANN-LA ROCHE INC.
- Delphine GAUFRETEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED PROTEIN DEGRADATION
- Publication number 20220372016
- Publication date Nov 24, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...
- Publication number 20220313826
- Publication date Oct 6, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20220313827
- Publication date Oct 6, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS FOR TREATING OSTEOPO...
- Publication number 20220305016
- Publication date Sep 29, 2022
- The General Hospital Corporation
- Marc Wein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF
- Publication number 20220281874
- Publication date Sep 8, 2022
- Dana-Farber Cancer Institure, Inc.
- Tinghu Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
- Publication number 20220133736
- Publication date May 5, 2022
- The General Hospital Corporation
- David E. Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADATION OF CYCLIN-DEPENDENT KINASE 8 (CDK8) BY CONJUGATION OF C...
- Publication number 20220112191
- Publication date Apr 14, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)
- Publication number 20220024929
- Publication date Jan 27, 2022
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEGRADATION OF CYCLIN-DEPENDENT KINASE 4/6 (CDK4/6) BY CONJUGATION...
- Publication number 20210340140
- Publication date Nov 4, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF
- Publication number 20210147388
- Publication date May 20, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF
- Publication number 20210147425
- Publication date May 20, 2021
- THE BROAD INSTITUTE, INC.
- Nathanael S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)
- Publication number 20210115051
- Publication date Apr 22, 2021
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20210106688
- Publication date Apr 15, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS
- Publication number 20210079005
- Publication date Mar 18, 2021
- HOFFMANN-LA ROCHE INC.
- Martin Duplessis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yanke Liang

Person

Patents Grantslast 30 patents

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Uses of salt-inducible kinase (SIK) inhibitors for treating osteopo...

Heterocyclic degronimers for target protein degradation

Spirocyclic degronimers for target protein degradation

Substituted piperidine Degronimers for Target Protein degradation

C3-carbon linked glutarimide degronimers for target protein degrada...

Uses of pyrimidopyrimidinones as SIK inhibitors

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...

Bicyclic urea kinase inhibitors and uses thereof

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

Isoindolinone and indazole compounds for the degradation of EGFR

N/O-linked Degrons and Degronimers for protein degradation

Uses of pyrimidopyrimidinones as SIK inhibitors

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...

Uses of salt-inducible kinase (SIK) inhibitors for treating osteopo...

Spirocyclic degronimers for target protein degradation

Imidazolyl kinase inhibitors and uses thereof

Bicyclic urea kinase inhibitors and uses thereof

Heterocyclic degronimers for target protein degradation

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of C...

Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation...

C3-carbon linked glutarimide degronimers for target protein degrada...

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of C...

Macrocyclic kinase inhibitors and uses thereof

Imidazolyl kinase inhibitors and uses thereof

Uses of salt-inducible kinase (SIK) inhibitors

Patents Applicationslast 30 patents

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...

USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS

THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...

N/O-Linked Degrons and Degronimers for Protein Degradation

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF

BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF

COMPOUNDS FOR TARGETED DEGRADATION OF RET

BRAF DEGRADERS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

BIFUNCTIONAL COMPOUNDS

TARGETED PROTEIN DEGRADATION

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...

SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS FOR TREATING OSTEOPO...

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF

USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS

DEGRADATION OF CYCLIN-DEPENDENT KINASE 8 (CDK8) BY CONJUGATION OF C...

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

DEGRADATION OF CYCLIN-DEPENDENT KINASE 4/6 (CDK4/6) BY CONJUGATION...

IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF

BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

COMPOUNDS